James E. Dixon
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 17
- Pluripotent Stem Cells Research 4
-
- Advanced Drug Delivery Systems 4
- Co-authors
- Kevin M. Shakesheff (13 shared papers)Chris N. Denning (5 shared papers)Gizem Osman (3 shared papers)Gavin E. Morris (3 shared papers)Hoda Maher Eltaher (6 shared papers)Fergal J. O’Brien (9 shared papers)Jane Chisholm (1 shared paper)Gregg A. Duncan (1 shared paper)
- Journals
- Journal of Controlled Release (4 papers)Acta Biomaterialia (3 papers)PLoS Biology (3 papers)Scientific Reports (2 papers)Bioactive Materials (2 papers)
- Partner nations
- United KingdomIrelandUnited States
In The Last Decade
James E. Dixon
44 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Biomaterials 196
- Pharmaceutical Science 108
- Molecular Biology 711
- Molecular Medicine 73
- Genetics 78
Countries citing papers authored by James E. Dixon
This map shows the geographic impact of James E. Dixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dixon more than expected).
Fields of papers citing papers by James E. Dixon
This network shows the impact of papers produced by James E. Dixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dixon. The network helps show where James E. Dixon may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Dixon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 178 | |
| 2 | 2013 | 106 | |
| 3 | 2016 | 99 | |
| 4 | 2007 | 85 | |
| 5 | 2014 | 83 | |
| 6 | 2017 | 78 | |
| 7 | 2014 | 68 | |
| 8 | 2019 | 67 | |
| 9 | 2011 | 56 | |
| 10 | 2014 | 55 | |
| 11 | 2018 | 50 | |
| 12 | 2010 | 47 | |
| 13 | 2019 | 40 | |
| 14 | 2011 | 37 | |
| 15 | 2020 | 35 | |
| 16 | 2019 | 32 | |
| 17 | 2018 | 30 | |
| 18 | 2011 | 29 | |
| 19 | 2019 | 29 | |
| 20 | 2020 | 29 |
About James E. Dixon
James E. Dixon is a scholar working on Molecular Biology, Pharmaceutical Science, Molecular Medicine, Biomaterials and Rheumatology, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Advanced Drug Delivery Systems (4 papers), Pluripotent Stem Cells Research (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Hydrogels: synthesis, properties, applications (4 papers), 3D Printing in Biomedical Research (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Bone Tissue Engineering Materials (3 papers). The work is most often cited by research in Biomaterials (196 citations), Pharmaceutical Science (108 citations), Molecular Biology (711 citations), Molecular Medicine (73 citations) and Genetics (78 citations). James E. Dixon has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Kevin M. Shakesheff, Chris N. Denning, Gizem Osman, Gavin E. Morris, Hoda Maher Eltaher, Fergal J. O’Brien, Jane Chisholm, Gregg A. Duncan, Jung Soo Suk and Justin S. Hanes. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia, PLoS Biology, Scientific Reports and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.